Jazz Pharmaceuticals (JAZZ) PT Raised to $283 at Morgan Stanley
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $244.64 +0.38%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 31
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 31
Join SI Premium – FREE
Morgan Stanley analyst Jeffrey Hung raised the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $283.00 (from $280.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Sprinklr Inc (CXM) PT Raised to $7.50 at Cantor Fitzgerald
- Jazz Pharmaceuticals (JAZZ) PT Raised to $310 at Needham
- Palo Alto Networks (PANW) PT Raised to $420 at DA Davidson on Strong Q4 Upside
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
